Bambusa Therapeutics Files for IPO to Fund Eczema Drug Trials
Bambusa Therapeutics has filed for an IPO to fund clinical trials of its eczema drug candidates, joining a crowded atopic dermatitis development field.
Topic
Biotech
Topic
Biotech
Bambusa Therapeutics Files for IPO to Bankroll Eczema Drug Trials
Bambusa Therapeutics is preparing an IPO to fund clinical trials of its eczema drug, Briefs Finance reports. Here's what dermatol…